STAGE IIIB LUNG NON-SMALL CELL CANCER AJCC V7
Clinical trials for STAGE IIIB LUNG NON-SMALL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG NON-SMALL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG NON-SMALL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced lung cancer: combining targeted therapy and immunotherapy shows promise
Disease control Recruiting nowThis study tests whether adding local treatments (like surgery or radiation) to the immunotherapy drug durvalumab can help control stage III lung cancer that has started to grow again after standard treatment. About 51 adults whose cancer has progressed after chemoradiation and d…
Matched conditions: STAGE IIIB LUNG NON-SMALL CELL CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New hope for Hard-to-Treat lung cancer: targeted pill shows promise
Disease control Recruiting nowThis study tests a pill called osimertinib in people with advanced lung cancer that has a specific genetic change (EGFR exon 20 insertion). The drug works by blocking signals that help cancer cells grow. About 46 participants will take the pill daily to see if it shrinks tumors o…
Matched conditions: STAGE IIIB LUNG NON-SMALL CELL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC